<?xml version="1.0" encoding="UTF-8"?><?xml-model type="application/xml-dtd" href="http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.1d3" specific-use="1.2" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="pmc">2310</journal-id>
<journal-title-group>
<journal-title specific-use="original" xml:lang="es">Universitas Medica</journal-title>
<abbrev-journal-title abbrev-type="publisher" xml:lang="es">Univ. Med.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">0041-9095</issn>
<issn pub-type="epub">2011-0839</issn>
<publisher>
<publisher-name>Pontificia Universidad Javeriana</publisher-name>
<publisher-loc>
<country>Colombia</country>
<email>revistascientificasjaveriana@gmail.com</email>
</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="art-access-id" specific-use="pmc">231068014024</article-id>
<article-id pub-id-type="doi">https://doi.org/10.11144/Javeriana.umed62-4.morb</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original</subject>
</subj-group>
</article-categories>
<title-group>
<article-title xml:lang="en">Morbidity and Mortality in Preterm Newborns Under 32 Weeks in a Neonatal Intensive Care Unit in the city of Bogotá (Colombia)</article-title>
<trans-title-group>
<trans-title xml:lang="es">Morbilidad y mortalidad en recién nacidos pretérmino menores de 32 semanas en una unidad de cuidados intensivos neonatal de la ciudad de Bogotá (Colombia)</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7079-5345</contrib-id>
<name name-style="western">
<surname>Puello Ávila</surname>
<given-names>Antonio Carlos</given-names>
</name>
<xref ref-type="corresp" rid="corresp1"><sup>a</sup></xref>
<xref ref-type="aff" rid="aff1"/>
<email>apuello@unbosque.edu.co</email>
</contrib>
<contrib contrib-type="author" corresp="no">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5357-8274</contrib-id>
<name name-style="western">
<surname>Laiseca Torres</surname>
<given-names>Édgar Felipe</given-names>
</name>
<xref ref-type="aff" rid="aff2"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution content-type="original">Neonatologist, Universidad El Bosque, Bogotá, Colombia. Pediatrician, Universidad de Cartagena, Cartagena, Colombia. Epidemiologist, Fundación Universitaria del Área Andina, Colombia. Physician, Universidad de Santander, Bucaramanga</institution>
<institution content-type="orgname">Universidad de Santander</institution>
<country country="CO">Colombia</country>
</aff>
<aff id="aff2">
<institution content-type="original">Resident Pediatrics Physician, Universidad El Bosque, Bogotá, Colombia. Physician, Universidad Surcolombiana, Neiva</institution>
<institution content-type="orgname">Universidad Surcolombiana</institution>
<country country="CO">Colombia</country>
</aff>
<author-notes>
<corresp id="corresp1"><sup>a</sup> Corresponding author: <email>apuello@unbosque.edu.co</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<season>Octubre-Diciembre</season>
<year>2021</year>
</pub-date>
<volume>62</volume>
<issue>4</issue>
<history>
<date date-type="received" publication-format="dd mes yyyy">
<day>17</day>
<month>06</month>
<year>2021</year>
</date>
<date date-type="accepted" publication-format="dd mes yyyy">
<day>13</day>
<month>08</month>
<year>2021</year>
</date>
</history>
<permissions>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional.</license-p>
</license>
</permissions>
<abstract xml:lang="en">
<title>Abstract</title>
<p><bold>Introduction:</bold> Adverse neonatal outcomes are associated with a great economic cost to health systems; this is directly related to the existing proportionality between the number of survivors and the disability rates in premature newborns; producing degrees of disability that vary from very mild to compromised quality of life. <bold>Objective</bold>: To describe the morbidity and mortality in newborns less than 32 weeks of gestational age and to determine the associated risk factors. <bold>Materials and methods:</bold> Cross-sectional study with an analytical component, which included all preterm newborns less than 32 weeks of gestational age, who were born between January 2018 and December 2020 and who continued their outpatient follow-up in the Mother Kangaroo program of the same institution. <bold>Results:</bold> 108 newborns were identified. The main outcomes were bronchopulmonary dysplasia with a frequency of 85.9% among survivors and an overall mortality of 27.7%. The strong association between septic shock and death is highlighted (ORa = 275; <italic>p</italic> = 0.004); in the same sense, gestational age (ORa = 83.3; <italic>p</italic> = 0.004<bold>). Conclusions:</bold> The bronchopulmonary dysplasia is the most important morbidity in this group with an associated significant overall mortality. The probability of dying in these newborns is explained by a lower gestational age (&lt;28 weeks), a lower hemoglobin level, a greater need for transfusions, and the presence of septic shock.</p>
</abstract>
<trans-abstract xml:lang="es">
<title>Resumen</title>
<p><bold>Introducción:</bold> Los desenlaces neonatales adversos se asocian con un gran costo económico para los sistemas de salud, y ello está relacionado con la proporcionalidad entre el número de sobrevivientes y las tasas de discapacidad en los recién nacidos prematuros, debido a que se producen grados de discapacidad que varían desde muy leves hasta muy graves. <bold>Objetivo:</bold> Describir la morbilidad y la mortalidad en recién nacidos menores de 32 semanas de edad gestacional y determinar los factores de riesgo asociados. <bold>Materiales y métodos:</bold> Estudio de corte transversal con componente analítico, que incluyó a todos los recién nacidos pretérmino menores de 32 semanas de edad gestacional que nacieron entre enero de 2018 y diciembre de 2020 y que continuaron su seguimiento ambulatorio en el programa Madre Canguro de la misma institución. <bold>Resultados: </bold>Se identificaron 108 recién nacidos. Los principales desenlaces fueron displasia broncopulmonar, con una frecuencia del 85,9 % entre los sobrevivientes, y una mortalidad global del 27,7 %. Se resalta la gran fuerza de asociación entre el choque séptico y el fallecimiento (ORa = 275; <italic>p</italic> = 0,004). En ese mismo sentido, la edad gestacional (ORa = 83,3; <italic>p</italic> = 0,004). <bold>Conclusiones:</bold> La displasia broncopulmonar es la morbilidad más importante en este grupo con una mortalidad global significativa asociada. La probabilidad de morir en estos recién nacidos se explica por menor edad gestacional (&lt;28 semanas), nivel de hemoglobina más bajo, mayor necesidad de transfusiones y la presencia de choque séptico.</p>
</trans-abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>morbidity</kwd>
<kwd>mortality</kwd>
<kwd>preterms</kwd>
<kwd>neonates</kwd>
</kwd-group>
<kwd-group xml:lang="es">
<title>Palabras clave</title>
<kwd>morbilidad</kwd>
<kwd>mortalidad</kwd>
<kwd>pretérminos</kwd>
<kwd>neonatos</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="5"/>
<equation-count count="0"/>
<ref-count count="30"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>How to cite</meta-name>
<meta-value>Puello Ávila AC, Laiseca Torres EF. Morbilidad y mortalidad en recién nacidos pretérmino menores de 32 semanas en una unidad de cuidados intensivos neonatal de la ciudad de Bogotá (Colombia). Univ. Med. 2021;62(4). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.11144/Javeriana.umed62-4.morb">https://doi.org/10.11144/Javeriana.umed62-4.morb</ext-link>
</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>There is growing concern about the directly proportional relationship between the number of survivors and the rates of disability in preterm newborns, especially concerning important sequelae such as neurodevelopment, retinopathy of prematurity, and bronchopulmonary dysplasia (<xref ref-type="bibr" rid="ref1">1</xref>), conditions clearly related to the immaturity of the organs at birth; as well as regarding the adverse effects of the therapies used to achieve their survival. These sequelae not only affect their quality of life but also have an impact on society as a whole, given the loss of skills (<xref ref-type="bibr" rid="ref2">2</xref>) and the economic cost to health systems (<xref ref-type="bibr" rid="ref3">3</xref>).</p>
<p>Bronchopulmonary dysplasia (BPD) is the most frequent cause of respiratory morbidity in premature infants who survive to the neonatal stage (<xref ref-type="bibr" rid="ref4">4</xref>). Its incidence is inversely proportional to gestational age and newborn weight (<xref ref-type="bibr" rid="ref5">5</xref>). This implies a long-term problem of pulmonary function, which results in the need for supplemental oxygen, increased susceptibility to respiratory infections, and significant associated mortality (<xref ref-type="bibr" rid="ref6">6</xref>).</p>
<p>There are a variety of neurodevelopmental sequelae that require adequate screening and follow-up (<xref ref-type="bibr" rid="ref7">7</xref>), particularly in this group, which presents greater neuropsychological complications (<xref ref-type="bibr" rid="ref8">8</xref>). There is a directly proportional relationship between neurological alteration and earlier gestational age at birth, with high rates in the incidence of transient and mild neurological abnormalities (<xref ref-type="bibr" rid="ref9">9</xref>), up to more severe and permanent forms of disability (<xref ref-type="bibr" rid="ref10">10</xref>).</p>
<p>Retinopathy of prematurity (ROP) has a spectrum ranging from spontaneous regression to bilateral retinal detachment and total blindness (<xref ref-type="bibr" rid="ref11">11</xref>). It is one of the main causes of infant blindness in third-world countries, and Colombia is responsible for 23.9% of cases (<xref ref-type="bibr" rid="ref12">12</xref>). The Cooperative Cryotherapy Group for Retinopathy of Prematurity found that ROP occurred in 66% of children with a birth weight of 1250 g or less and 82% of children with a birth weight of less than 1000 g (<xref ref-type="bibr" rid="ref13">13</xref>).</p>
<p>Thus, we have a group of pathologies that are a direct product of the prematurity of the newborn and its subsequent postnatal stage, which shares many risk factors that influence the development of these, and on many occasions have the possibility of being prevented. The objective of the research was to describe morbidity and mortality in newborns under 32 weeks of gestational age attended in a neonatal intensive care unit in Bogota (Colombia), between January 2018 and December 2020, and to determine the associated factors.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title><italic>Type of study and design</italic></title>
<p>An observational, cross-sectional study with an analytical component was carried out. The inclusion criteria were all newborns under 32 weeks of gestational age, attended in a neonatal intensive care unit of a public hospital of high obstetric complexity and reference site in the city of Bogota, between January 2018, and December 2020, and who continued their follow-up in the Mother Kangaroo program of the same institution.</p>
<p>It should be clarified that patients with complications typical of prematurity, such as respiratory distress syndrome, enterocolitis, intraventricular hemorrhage, among others, are part of the inclusion criteria. The exclusion criteria were all newborns with major malformations, genetic diseases and serious or life-threatening diseases not related to the complications of prematurity.</p>
</sec>
<sec>
<title><italic>Sample collection and processing</italic></title>
<p>A non-probabilistic, convenience sampling was performed, in which all newborns who met the inclusion criteria were included. The mortality and morbidity of these patients was reviewed through inpatient and outpatient medical records, the single registry of affiliates and the outpatient records of the Mother Kangaroo program, pediatric neurology, physiatry, pediatric ophthalmology and pediatric pulmonology, where each of the comorbidities presented by the patients during their follow-up were described. This was determined by clinical, imaging or paraclinical findings.</p>
</sec>
<sec>
<title><italic>Statistical analysis</italic></title>
<p>Averages and medians were estimated for quantitative variables, as well as their respective measures of dispersion, according to the fit of the data to the normal distribution. Qualitative variables were presented as frequencies and percentages. Death registration and BPD were considered as dependent variables for the construction of the bivariate analysis. Averages were compared with Student's t-test; while medians were compared with the Mann-Whitney U test. Percentages were contrasted with the chi-square test (χ²), when expected values &gt;5 were identified; otherwise, Fisher's exact test was used.</p>
<p>Statistically significant differences were taken into account as those with p values &lt; 0.2 to be incorporated into the initial multivariate model. The logistic regression model was constructed based on the Backward stepwise strategy, in which the variables generating the highest p values were eliminated one by one. Finally, the most significant variables and those of greater relevance were left out because they were potential confounders. The analysis was performed in Stata <italic>software</italic>, version 12.</p>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<p>During the study period, 157 newborns under 32 weeks were identified (33/629 births in 2020, 70/2198 births in 2019, and 54/1948 births in 2018). In the last year, the number of deliveries in the institution was affected by functional changes in the health network, given by the SARS-CoV-2 pandemic. Of the newborns, 108 met the inclusion criteria and were finally part of the analysis.</p>
<p>Concerning maternal characteristics, 9.26 % were adolescents; while 13.8 % were elderly mothers; 37 % were first pregnancy women; 13.9 % were of foreign origin, and 59.3 % were mothers in the subsidized health regime. Regarding antenatal care, 57/82 (69 %) received a complete pulmonary maturation scheme. Cesarean delivery occurred in 67.6 % of the mothers. The other maternal characteristics and information on the perinatal period are presented in <xref ref-type="table" rid="gt1">Table 1</xref>.</p>
<p>
<table-wrap id="gt1">
<label>Table 1.</label>
<caption>
<title>Maternal characteristics and perinatal history of newborns under 32 weeks of age, 2018-2020</title>
<p>f: Fisher's exact test; t: Student's t-test.</p>
</caption>
<alt-text>Table 1. Maternal characteristics and perinatal history of newborns under 32 weeks of age, 2018-2020</alt-text>
<graphic xlink:href="231068014024_gt2.png" position="anchor" orientation="portrait"/>
</table-wrap>
</p>
<p>Among the newborns who developed severe respiratory distress syndrome (RDS), only 20 (47.6 %) received complete pulmonary maturation and 29 (69 %) required advanced resuscitation at birth. Regarding the characteristics of the newborn, the management in the delivery room and the clinical behavior in the early postnatal period are described in <xref ref-type="table" rid="gt2">Table 2</xref>.</p>
<p>
<table-wrap id="gt2">
<label>Table 2.</label>
<caption>
<title>Clinical and paraclinical findings and characteristics of the initial care of newborns less than 32 weeks of gestation, 2018-2020</title>
<p>f: Fisher's exact test; t: Student's t-test.</p>
</caption>
<alt-text>Table 2. Clinical and paraclinical findings and characteristics of the initial care of newborns less than 32 weeks of gestation, 2018-2020</alt-text>
<graphic xlink:href="231068014024_gt3.png" position="anchor" orientation="portrait"/>
</table-wrap>
</p>
<p>
<xref ref-type="table" rid="gt3">Table 3</xref> shows the clinical outcomes. Among the sequelae explored among the surviving patients, no cases of infantile cerebral palsy, hypoxic-ischemic encephalopathy, or blindness were identified. The clinical outcomes identified were: one case of moderate retinopathy, five patients diagnosed with hypoacusis, eight patients with neurodevelopmental disorders, two with epilepsy, and one with hydrocephalus (who required surgical management); in addition to one case of periventricular leukomalacia.</p>
<p>
<table-wrap id="gt3">
<label>Table 3.</label>
<caption>
<title>Inpatient and outpatient follow-up outcomes of preterm newborns, 2018-2020</title>
<p>f: Fisher's exact test; t: Student's t-test.</p>
</caption>
<alt-text>Table 3. Inpatient and outpatient follow-up outcomes of preterm newborns, 2018-2020</alt-text>
<graphic xlink:href="231068014024_gt4.png" position="anchor" orientation="portrait"/>
</table-wrap>
</p>
<p>In patients who did not receive the full steroid regimen versus those who did receive the full regimen, neurodevelopmental impairment (33.3 % vs. 22.2 %; p = 0.618), enterocolitis (30.7 % vs. 17.54 %; p = 0.250), and early sepsis (19.23 % vs. 38.9 %; p = 0.129) were present. Of the survivors, 80.7 % (n = 63) received palivizumab prophylaxis before discharge. Nine patients developed bronchiolitis after hospital discharge, of which four (44.4 %) cases were found to have received a full palivizumab regimen.</p>
<p>Thirty deaths were identified, which estimates mortality in this population of 27.7%. Within the cohort of deaths, it was striking that there was a higher frequency of incomplete pulmonary maturation with corticosteroids (53.3 % vs. 44.9 %; p = 0.430), sepsis as the main diagnosis associated with RDS in the newborn (46.7 % vs. 24.4 %; p = 0.024), and the need for ventilatory support at birth (100 % vs. 96.2 %; p = 0.559). The mean number of days of hospitalization in deceased participants found was 6.8 days (vs. 54.2 days among those who survived; p ≤ 0.001), with similar results for mean ventilator days (6.5 days vs. 28.7 days; p ≤ 0.001).</p>
<p>Based on the bivariate analysis presented, a multivariate logistic regression model was constructed to identify the factors associated with mortality in this population (<xref ref-type="table" rid="gt4">Table 4</xref>).</p>
<p>
<table-wrap id="gt4">
<label>Table 4.</label>
<caption>
<title>Multivariate analysis of factors associated with mortality in preterm infants, 2018-2020</title>
<p>Pseudo R<sup>2</sup> = 0.709 (<italic>p</italic>-value ≤ 0.001).</p>
</caption>
<alt-text>Table 4. Multivariate analysis of factors associated with mortality in preterm infants, 2018-2020</alt-text>
<graphic xlink:href="231068014024_gt5.png" position="anchor" orientation="portrait"/>
</table-wrap>
</p>
<p>The outcome of BPD occurred in 67 (85.9 %) of the 78 survivors within this population (<xref ref-type="table" rid="gt5">Table 5</xref>). Of these, 43 received full pulmonary maturation; 35.9 % (n = 28) developed severe respiratory distress syndrome at birth, and 37 were discharged with a need for home oxygen (median days of oxygen dependency = 30; RIQ = 10-90). Within the BPD cohort there is a higher proportion in the incidence of enterocolitis (22.4 % vs. 0 %; p = 0.110) and sepsis (68.6 % vs. 18.2 %; p = 0.002). Regarding surfactant use, 78.2 % (n = 61) received one dose and 6.4 % (n = 5) received at least two doses. The INSURE technique was successful in 28.2 % (n = 22); the success rate was higher in children with mild respiratory distress (34.8 %) and slightly lower in moderate and severe respiratory distress (28 % and 25 %, respectively; p = 0.862). In the multivariate analysis of factors associated with bronchopulmonary dysplasia, we observed how anemia constituted the most important risk factor for its development (ORa: 25.8; CI95 %: 4.37-149.9; p ≤ 0.001; pseudo-R²: 0.352, with p-value ≤ 0.001).</p>
<p>
<table-wrap id="gt5">
<label>Table 5.</label>
<caption>
<title>Comparative in terms of bronchopulmonary dysplasia among preterm newborns, 2018-2020</title>
</caption>
<alt-text>Table 5. Comparative in terms of bronchopulmonary dysplasia among preterm newborns, 2018-2020</alt-text>
<graphic xlink:href="231068014024_gt6.png" position="anchor" orientation="portrait"/>
</table-wrap>
</p>
</sec>
<sec sec-type="discussion">
<title>Discussion </title>
<p>The results obtained show a high rate of respiratory sequelae. Currently, BPD has a better prognosis and fewer long-term sequelae, but its incidence has not decreased over time. We found that children with lower birth weight, lower gestational age and longer duration of mechanical ventilation presented higher frequencies. There is a directly proportional relationship between the time of oxygen dependency and pulmonary compromise in terms of BPD (<xref ref-type="bibr" rid="ref14">14</xref>), and inversely proportional to gestational age and newborn weight, ranging from 7% to 52% in children weighing less than 750 g (<xref ref-type="bibr" rid="ref15">15</xref>).</p>
<p>Anemia was an independent risk factor for BPD. Suboptimal hemoglobin concentrations are associated with greater oxygenation impairment and longer ventilation times. The adverse effects of prolonged ventilation are strongly associated with adverse outcomes, and include, in addition, ROP and neurological disturbances. Different studies have shown how newborn RDS, sepsis, ventilator-associated pneumonia, mechanical ventilation, and red blood cell transfusion are the most important common risk factors for the development of BPD (<xref ref-type="bibr" rid="ref16">16</xref>). Other factors found were the need for exogenous pulmonary surfactant at birth, patent ductus arteriosus, and necrotizing enterocolitis, frequent findings in other studies (<xref ref-type="bibr" rid="ref17">17</xref>).</p>
<p>In patients in whom follow-up was completed, it was observed that the higher the chronological age after discharge, the lower the dependence on oxygen. In the first two years, hospitalizations due to respiratory causes are frequent (<xref ref-type="bibr" rid="ref18">18</xref>), and although respiratory morbidity decreases with age, these children may present respiratory symptoms, need for oxygen, and alterations in pulmonary function beyond school age, and even in adolescence (<xref ref-type="bibr" rid="ref19">19</xref>).</p>
<p>Despite advances in neonatal care, which resulted in a decrease in morbidity, limited progress has been made in reducing mortality, which was our second most important outcome, related to earlier gestational age and lower birth weight. In general, prematurity constitutes the main cause of perinatal mortality in Colombia, with records of up to 24.2 % of cases (<xref ref-type="bibr" rid="ref20">20</xref>), somewhat lower than our record, but with similarities, in that infection constituted the variable with the highest lethality (<xref ref-type="bibr" rid="ref21">21</xref>).</p>
<p>These findings show only early neurodevelopmental findings, and although severe neurological sequelae can usually be diagnosed during the first year of life (<xref ref-type="bibr" rid="ref22">22</xref>), there is a larger group of sequelae that require adequate follow-up for screening (<xref ref-type="bibr" rid="ref7">7</xref>). There are differences in brain growth and development among children and adolescents born preterm (<xref ref-type="bibr" rid="ref23">23</xref>); however, although most survivors are free of major disabling conditions, many more subtle conditions are now evident in survivors, and this is closely related to the degree of immaturity at birth (<xref ref-type="bibr" rid="ref24">24</xref>), including learning disabilities and visual and hearing impairments (<xref ref-type="bibr" rid="ref25">25</xref>).</p>
<p>The development of retinopathy is closely related to early exposure to high amounts of oxygen; however, the frequency of ROP reported was almost nil, contrary to other publications, where an alteration has been reported, especially in the very low weight preterm baby and higher incidence at lower gestational weeks (<xref ref-type="bibr" rid="ref26">26</xref>). These findings could be explained by adequate control of oxygenation limits, among other interventions. Wide fluctuations in oxygen saturation are most associated with an increased risk of severe ROP. According to its severity, it can cause severe visual impairment, and moderate forms regress with little or no impairment of visual function; but more severe forms can cause loss of visual acuity and even blindness (<xref ref-type="bibr" rid="ref27">27</xref>).</p>
<p>The use of surfactant decreased the need for invasive mechanical ventilation. Overall, the results show a substantial reduction in mortality and respiratory morbidity (<xref ref-type="bibr" rid="ref28">28</xref>). Noninvasive methods of ventilation were used more frequently in infants who did not develop BPD; consequently, these types of therapies could be considered with the clinical goal of reducing BPD, despite the variability in published results (<xref ref-type="bibr" rid="ref29">29</xref>).</p>
<p>Maternal steroid administration was not found to be associated with a lower incidence of BPD. Studies indicate benefits of corticosteroids in reducing the risks of perinatal death, neonatal death, moderate/severe RDS, intraventricular hemorrhage, necrotizing enterocolitis, need for mechanical ventilation, and systemic infections in the first 48 hours of life but not in chronic lung disease or in reducing neurodevelopmental delay in infancy (<xref ref-type="bibr" rid="ref30">30</xref>).</p>
</sec>
<sec sec-type="conclusions">
<title>Conclusions</title>
<p>The incidence of BPD in preterm infants younger than 32 weeks is high, and this constitutes the most important morbidity in this group, with a significant associated overall mortality. In terms of mortality, the probability of death in these newborns is explained by lower gestational age (&lt;28 weeks), lower hemoglobin concentrations, greater need for transfusions, and the presence of septic shock.</p>
</sec>
<sec>
<title>Conflict of interest</title>
<p>The authors declare that there is no actual, potential, or potentially perceived conflict of interest (financial, professional, or personal) that could result in bias in the publication of this work.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="ref1">
<label>1.</label>
<mixed-citation>1. Vwalika B, Price JT, Rosenbaum A, Stringer JSA. Reducing the global burden of preterm births. Lancet Glob Health. 2019;7(4):e415.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vwalika</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Rosenbaum</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stringer</surname>
<given-names>JSA</given-names>
</name>
</person-group>
<article-title>Reducing the global burden of preterm births</article-title>
<source>Lancet Glob Health</source>
<year>2019</year>
<volume>7</volume>
<issue>4</issue>
<elocation-id>e415</elocation-id>
</element-citation>
</ref>
<ref id="ref2">
<label>2.</label>
<mixed-citation>2. Seethapathy J, Boominathan P, Uppunda AK, Ninan B. Changes in auditory brainstem response in very preterm and late preterm infants. Int J Pediatr Otorhinolaryngol. 2019;121:88-94.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seethapathy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Boominathan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Uppunda</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Ninan</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Changes in auditory brainstem response in very preterm and late preterm infants</article-title>
<source>Int J Pediatr Otorhinolaryngol</source>
<year>2019</year>
<volume>121</volume>
<fpage>88</fpage>
<lpage>94</lpage>
</element-citation>
</ref>
<ref id="ref3">
<label>3.</label>
<mixed-citation>3. Frey HA, Klebanoff MA. The epidemiology, etiology, and costs of preterm birth. Semin Fetal Neonatal Med. 2016;21(2):68-73.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frey</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Klebanoff</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>The epidemiology, etiology, and costs of preterm birth</article-title>
<source>Semin Fetal Neonatal Med</source>
<year>2016</year>
<volume>21</volume>
<issue>2</issue>
<fpage>68</fpage>
<lpage>73</lpage>
</element-citation>
</ref>
<ref id="ref4">
<label>4.</label>
<mixed-citation>4. Tracy MK, Berkelhamer SK. Bronchopulmonary dysplasia and pulmonary outcomes of prematurity. Pediatr Ann. 2019;48(4):e148-53.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tracy</surname>
<given-names>MK</given-names>
</name>
</person-group>
<article-title>Berkelhamer SK. Bronchopulmonary dysplasia and pulmonary outcomes of prematurity</article-title>
<source>Pediatr Ann</source>
<year>2019</year>
<volume>48</volume>
<issue>4</issue>
<elocation-id>e148-53</elocation-id>
</element-citation>
</ref>
<ref id="ref5">
<label>5.</label>
<mixed-citation>5. Bancalari E, Claure N, Sosenko IR. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol. 2003;8(1):63-71.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bancalari</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Claure</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sosenko</surname>
<given-names>IR</given-names>
</name>
</person-group>
<article-title>Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition</article-title>
<source>Semin Neonatol</source>
<year>2003</year>
<volume>8</volume>
<issue>1</issue>
<fpage>63</fpage>
<lpage>71</lpage>
</element-citation>
</ref>
<ref id="ref6">
<label>6.</label>
<mixed-citation>6. Reiterer F, Scheuchenegger A, Resch B, Maurer-Fellbaum U, Avian A, Urlesberger B. Bronchopulmonary dysplasia in very preterm infants: outcome up to preschool age, in a single center of Austria. Pediatr Int. 2019;61(4):381-7.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reiterer</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Scheuchenegger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Resch</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Maurer-Fellbaum</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Avian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Urlesberger</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Bronchopulmonary dysplasia in very preterm infants: outcome up to preschool age, in a single center of Austria</article-title>
<source>Pediatr Int</source>
<year>2019</year>
<volume>61</volume>
<issue>4</issue>
<fpage>381</fpage>
<lpage>387</lpage>
</element-citation>
</ref>
<ref id="ref7">
<label>7.</label>
<mixed-citation>7. García Reymundo M, Hurtado Suazo JA, Calvo Aguilar MJ, et al. Recomendaciones de seguimiento del prematuro tardío. An Pediatr. 2019;90(5):318.e1-318.e8. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.anpedi.2019.01.008">https://doi.org/10.1016/j.anpedi.2019.01.008</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>García Reymundo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hurtado Suazo</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Calvo Aguilar</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Recomendaciones de seguimiento del prematuro tardío</article-title>
<source>An Pediatr</source>
<year>2019</year>
<volume>90</volume>
<issue>5</issue>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.anpedi.2019.01.008">https://doi.org/10.1016/j.anpedi.2019.01.008</ext-link>
</comment>
<pub-id pub-id-type="doi">10.1016/j.anpedi.2019.01.008</pub-id>
<elocation-id>318.e1-318.e8</elocation-id>
</element-citation>
</ref>
<ref id="ref8">
<label>8.</label>
<mixed-citation>8. Castro Carrasco P, Barraza Rodríguez P. Diferencias cerebrales en prematuros y su relación con el desarrollo de sus funciones cognitivas. Terap Psicol [internet]. 2007;25(2):183-8. Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.redalyc.org/articulo.oa?id=78525209">https://www.redalyc.org/articulo.oa?id=78525209</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castro Carrasco</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Barraza Rodríguez</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Diferencias cerebrales en prematuros y su relación con el desarrollo de sus funciones cognitivas</article-title>
<source>Terap Psicol</source>
<year>2007</year>
<volume>25</volume>
<issue>2</issue>
<fpage>183</fpage>
<lpage>188</lpage>
<comment>Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.redalyc.org/articulo.oa?id=78525209">https://www.redalyc.org/articulo.oa?id=78525209</ext-link>
</comment>
</element-citation>
</ref>
<ref id="ref9">
<label>9.</label>
<mixed-citation>9. Brandt I, Sticker EJ, Höcky M, Lentze MJ. Transient abnormal neurologic signs (TANS) in a longitudinal study of very low birth weight preterm infants. Early Hum Dev. 2000;59(2):107-26.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brandt</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Sticker</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Höcky</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lentze</surname>
<given-names>MJ</given-names>
</name>
</person-group>
<article-title>Transient abnormal neurologic signs (TANS) in a longitudinal study of very low birth weight preterm infants</article-title>
<source>Early Hum Dev</source>
<year>2000</year>
<volume>59</volume>
<issue>2</issue>
<fpage>107</fpage>
<lpage>126</lpage>
</element-citation>
</ref>
<ref id="ref10">
<label>10.</label>
<mixed-citation>10. Degos V, Loron G, Mantz J, Gressens P. Neuroprotective strategies for the neonatal brain. Anesth Analg. 2008;106(6):1670-80.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Degos</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Loron</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mantz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gressens</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Neuroprotective strategies for the neonatal brain</article-title>
<source>Anesth Analg</source>
<year>2008</year>
<volume>106</volume>
<issue>6</issue>
<fpage>1670</fpage>
<lpage>1680</lpage>
</element-citation>
</ref>
<ref id="ref11">
<label>11.</label>
<mixed-citation>11. Dogra MR, Katoch D, Dogra M. An update on retinopathy of prematurity (ROP). Indian J Pediatr. 2017;84(12):930-6.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dogra</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Katoch</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dogra</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>An update on retinopathy of prematurity (ROP)</article-title>
<source>Indian J Pediatr</source>
<year>2017</year>
<volume>84</volume>
<issue>12</issue>
<fpage>930</fpage>
<lpage>936</lpage>
</element-citation>
</ref>
<ref id="ref12">
<label>12.</label>
<mixed-citation>12. Giraldo M, Hurtado A, Donado J, Molina M. Epidemiología de la retinopatía del prematuro en Medellín, 2003-2008. Iatreia [internet]. 2011;24(3):250-8. Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.redalyc.org/articulo.oa?id=180522550003">https://www.redalyc.org/articulo.oa?id=180522550003</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giraldo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hurtado</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Donado</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Molina</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Epidemiología de la retinopatía del prematuro en Medellín, 2003-2008</article-title>
<source>Iatreia</source>
<year>2011</year>
<volume>24</volume>
<issue>3</issue>
<fpage>250</fpage>
<lpage>258</lpage>
<comment>Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.redalyc.org/articulo.oa?id=180522550003">https://www.redalyc.org/articulo.oa?id=180522550003</ext-link>
</comment>
</element-citation>
</ref>
<ref id="ref13">
<label>13.</label>
<mixed-citation>13. Multicenter trial of cryotherapy for retinopathy of prematurity. Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1988;106(4):471-9.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Multicenter trial of cryotherapy for retinopathy of prematurity</collab>
</person-group>
<article-title>Preliminary results. Cryotherapy for Retinopathy of Prematurity Cooperative Group</article-title>
<source>Arch Ophthalmol</source>
<year>1988</year>
<volume>106</volume>
<issue>4</issue>
<fpage>471</fpage>
<lpage>479</lpage>
</element-citation>
</ref>
<ref id="ref14">
<label>14.</label>
<mixed-citation>14. Kiciński P, Kęsiak M, Nowiczewski M, Gulczyńska E. Bronchopulmonary dysplasia in very and extremely low birth weight infants - analysis of selected risk factors. Pol Merkur Lekarski. 2017;42(248):71-5.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiciński</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kęsiak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nowiczewski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gulczyńska</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Bronchopulmonary dysplasia in very and extremely low birth weight infants - analysis of selected risk factors</article-title>
<source>Pol Merkur Lekarski</source>
<year>2017</year>
<volume>42</volume>
<issue>248</issue>
<fpage>71</fpage>
<lpage>75</lpage>
</element-citation>
</ref>
<ref id="ref15">
<label>15.</label>
<mixed-citation>15. Geary C, Caskey M, Fonseca R, Malloy M. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study. Pediatrics. 2008;121(1):89-96.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geary</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Caskey</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fonseca</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Malloy</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study</article-title>
<source>Pediatrics</source>
<year>2008</year>
<volume>121</volume>
<issue>1</issue>
<fpage>89</fpage>
<lpage>96</lpage>
</element-citation>
</ref>
<ref id="ref16">
<label>16.</label>
<mixed-citation>16. Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units. Zhonghua Er Ke Za Zhi. 2019;57(1):33-9.</mixed-citation>
<element-citation publication-type="journal">
<article-title>Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units</article-title>
<source>Zhonghua Er Ke Za Zhi</source>
<year>2019</year>
<volume>57</volume>
<issue>1</issue>
<fpage>33</fpage>
<lpage>39</lpage>
</element-citation>
</ref>
<ref id="ref17">
<label>17.</label>
<mixed-citation>17. Tapia JL, Agost D, Alegria A, Standen J, Escobar M, Grandi C, et al. Bronchopulmonary dysplasia: incidence, risk factors and resource utilization in a population of South American very low birth weight infants. J Pediatr (Rio J). 2006;82(1):15-20. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2223/JPED.1431">https://doi.org/10.2223/JPED.1431</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tapia</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Agost</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Alegria</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Standen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Escobar</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Grandi</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Bronchopulmonary dysplasia: incidence, risk factors and resource utilization in a population of South American very low birth weight infants</article-title>
<source>J Pediatr (Rio J)</source>
<year>2006</year>
<volume>82</volume>
<issue>1</issue>
<fpage>15</fpage>
<lpage>20</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2223/JPED.1431">https://doi.org/10.2223/JPED.1431</ext-link>
</comment>
<pub-id pub-id-type="doi">10.2223/JPED.1431</pub-id>
</element-citation>
</ref>
<ref id="ref18">
<label>18.</label>
<mixed-citation>18. Chaw PS, Hua L, Cunningham S, Campbell H, Mikolajczyk R, Nair H, et al. Respiratory syncytial virus-associated acute lower respiratory infections in children with bronchopulmonary dysplasia: systematic review and meta-analysis. J Infect Dis. 2020;222(Suppl 7):S620-7. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/infdis/jiz492">https://doi.org/10.1093/infdis/jiz492</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaw</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cunningham</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mikolajczyk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nair</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Respiratory syncytial virus-associated acute lower respiratory infections in children with bronchopulmonary dysplasia: systematic review and meta-analysis</article-title>
<source>J Infect Dis</source>
<year>2020</year>
<volume>222</volume>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/infdis/jiz492">https://doi.org/10.1093/infdis/jiz492</ext-link>
</comment>
<pub-id pub-id-type="doi">10.1093/infdis/jiz492</pub-id>
<elocation-id>S620-7</elocation-id>
<supplement>7</supplement>
</element-citation>
</ref>
<ref id="ref19">
<label>19.</label>
<mixed-citation>19. Voynow JA. “New” bronchopulmonary dysplasia and chronic lung disease. Paediatr Respir Rev. 2017;24:17-18.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Voynow</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>“New” bronchopulmonary dysplasia and chronic lung disease</article-title>
<source>Paediatr Respir Rev</source>
<year>2017</year>
<volume>24</volume>
<fpage>17</fpage>
<lpage>18</lpage>
</element-citation>
</ref>
<ref id="ref20">
<label>20.</label>
<mixed-citation>20. Instituto Nacional de Salud (INS). Mortalidad perinatal y neonatal y morbilidad materna extrema neonatal. Boletín Epidemiológico Semanal (BES) [internet]. 2020 feb 23-29. Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2020_Boletin_epidemiologico_semana_9.pdf">https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2020_Boletin_epidemiologico_semana_9.pdf</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Instituto Nacional de Salud (INS)</collab>
</person-group>
<article-title>Mortalidad perinatal y neonatal y morbilidad materna extrema neonatal</article-title>
<source>Boletín Epidemiológico Semanal (BES)</source>
<year>2020</year>
<comment>Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2020_Boletin_epidemiologico_semana_9.pdf">https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2020_Boletin_epidemiologico_semana_9.pdf</ext-link>
</comment>
</element-citation>
</ref>
<ref id="ref21">
<label>21.</label>
<mixed-citation>21. Lehtonen L, Gimeno A, Parra-Llorca A, Vento M. Early neonatal death: a challenge worldwide. Semin Fetal Neonatal Med. 2017;22(3):153-60.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehtonen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gimeno</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Parra-Llorca</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Vento</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Early neonatal death: a challenge worldwide</article-title>
<source>Semin Fetal Neonatal Med</source>
<year>2017</year>
<volume>22</volume>
<issue>3</issue>
<fpage>153</fpage>
<lpage>160</lpage>
</element-citation>
</ref>
<ref id="ref22">
<label>22.</label>
<mixed-citation>22. Pallás Alonso C, García González P, Jiménez Moya A, et al. Protocolo de seguimiento para el recién nacido menor de 1.500 g o menor de 32 semanas de edad gestación. An Pediatr (Barc). 2018;88(4):229.e1-229.e10. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.anpedi.2017.12.010">https://doi.org/10.1016/j.anpedi.2017.12.010</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pallás Alonso</surname>
<given-names>C</given-names>
</name>
<name>
<surname>García González</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Jiménez Moya</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Protocolo de seguimiento para el recién nacido menor de 1.500 g o menor de 32 semanas de edad gestación</article-title>
<source>An Pediatr (Barc)</source>
<year>2018</year>
<volume>88</volume>
<issue>4</issue>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.anpedi.2017.12.010">https://doi.org/10.1016/j.anpedi.2017.12.010</ext-link>
</comment>
<pub-id pub-id-type="doi">10.1016/j.anpedi.2017.12.010</pub-id>
<elocation-id>229.e1-229.e10</elocation-id>
</element-citation>
</ref>
<ref id="ref23">
<label>23.</label>
<mixed-citation>23. Counsell SJ, Boardman JP. Differential brain growth in the infant born preterm: current knowledge and future developments from brain imaging. Semin Fetal Neonatal Med. 2005;10(5):403-10.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Counsell</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Boardman</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Differential brain growth in the infant born preterm: current knowledge and future developments from brain imaging</article-title>
<source>Semin Fetal Neonatal Med</source>
<year>2005</year>
<volume>10</volume>
<issue>5</issue>
<fpage>403</fpage>
<lpage>410</lpage>
</element-citation>
</ref>
<ref id="ref24">
<label>24.</label>
<mixed-citation>24. Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ. Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA. 2002;288(6):728-37.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhutta</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Cleves</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Casey</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Cradock</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Anand</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis</article-title>
<source>JAMA</source>
<year>2002</year>
<volume>288</volume>
<issue>6</issue>
<fpage>728</fpage>
<lpage>737</lpage>
</element-citation>
</ref>
<ref id="ref25">
<label>25.</label>
<mixed-citation>25. Di Fiore JM, MacFarlane PM, Martin RJ. Intermittent hypoxemia in preterm infants. Clin Perinatal. 2019;46(3):553-65.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Fiore</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>MacFarlane</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>RJ</given-names>
</name>
</person-group>
<article-title>Intermittent hypoxemia in preterm infants</article-title>
<source>Clin Perinatal</source>
<year>2019</year>
<volume>46</volume>
<issue>3</issue>
<fpage>553</fpage>
<lpage>565</lpage>
</element-citation>
</ref>
<ref id="ref26">
<label>26.</label>
<mixed-citation>26. Coats DK. Retinopathy of prematurity: treatment and prognosis. UpToDate [internet]. 2020. Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.uptodate.com/contents/retinopathy-of-prematurity-treatment-and-prognosis">https://www.uptodate.com/contents/retinopathy-of-prematurity-treatment-and-prognosis</ext-link>
</mixed-citation>
<element-citation publication-type="webpage">
<person-group person-group-type="author">
<name>
<surname>Coats</surname>
<given-names>DK</given-names>
</name>
</person-group>
<article-title>Retinopathy of prematurity: treatment and prognosis</article-title>
<source>UpToDate</source>
<year>2020</year>
<comment>Disponible en: <ext-link ext-link-type="uri" xlink:href="https://www.uptodate.com/contents/retinopathy-of-prematurity-treatment-and-prognosis">https://www.uptodate.com/contents/retinopathy-of-prematurity-treatment-and-prognosis</ext-link>
</comment>
</element-citation>
</ref>
<ref id="ref27">
<label>27.</label>
<mixed-citation>27. Sola A, Chow L, Rogido M. Retinopatía de la prematuridad y oxigenoterapia: una relación cambiante. An Pediatr (Barc). 2005;62(1):48-63. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1157/13070182">https://doi.org/10.1157/13070182</ext-link>
</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sola</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chow</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rogido</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Retinopatía de la prematuridad y oxigenoterapia: una relación cambiante</article-title>
<source>An Pediatr (Barc)</source>
<year>2005</year>
<volume>62</volume>
<issue>1</issue>
<fpage>48</fpage>
<lpage>63</lpage>
<comment>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1157/13070182">https://doi.org/10.1157/13070182</ext-link>
</comment>
<pub-id pub-id-type="doi">10.1157/13070182</pub-id>
</element-citation>
</ref>
<ref id="ref28">
<label>28.</label>
<mixed-citation>28. Polin RA, Carlo WA; Committee on Fetus and Newborn; American Academy of Pediatrics. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics. 2014;133(1):156-63.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polin</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Carlo</surname>
<given-names>WA</given-names>
</name>
<collab>Committee on Fetus and Newborn</collab>
<collab>American Academy of Pediatrics</collab>
</person-group>
<article-title>Surfactant replacement therapy for preterm and term neonates with respiratory distress</article-title>
<source>Pediatrics</source>
<year>2014</year>
<volume>133</volume>
<issue>1</issue>
<fpage>156</fpage>
<lpage>163</lpage>
</element-citation>
</ref>
<ref id="ref29">
<label>29.</label>
<mixed-citation>29. Hussain WA, Marks JD. Approaches to noninvasive respiratory support in preterm infants: from CPAP to NAVA. Neoreviews. 2019;20(4):e213-e221.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussain</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Approaches to noninvasive respiratory support in preterm infants: from CPAP to NAVA</article-title>
<source>Neoreviews</source>
<year>2019</year>
<volume>20</volume>
<issue>4</issue>
<elocation-id>e213-e221</elocation-id>
</element-citation>
</ref>
<ref id="ref30">
<mixed-citation>30<bold>.  </bold>Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454.</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Medley</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Dalziel</surname>
<given-names>SR</given-names>
</name>
</person-group>
<article-title>Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth</article-title>
<source>Cochrane Database Syst Rev</source>
<year>2017</year>
<volume>3</volume>
<issue>3</issue>
<comment>CD004454</comment>
</element-citation>
</ref>
</ref-list>
</back>
</article>